LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
LMPR0106040006
|
Viridominic acid A
|
6alpha,16beta-diacetoxy-11-oxo-3alpha,7beta-dihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C33H48O9
|
588.329835
|
LMPR0106040007
|
Viridominic acid B
|
6alpha,16beta-diacetoxy-11-oxo-3alpha,7beta,12alpha-trihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C33H48O10
|
604.324750
|
LMPR0106040008
|
Viridominic acid C
|
6alpha,16beta-diacetoxy-3alpha,7beta,11beta-trihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C33H50O9
|
590.345485
|
LMPR0106040009
|
Cephalosporin P1
|
6alpha,16beta-diacetoxy-3alpha,7beta-dihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C33H50O8
|
574.350570
|
LMPR0106040010
|
Isocephalosporin P1
|
7beta,16beta-diacetoxy-3alpha,6alpha-dihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C33H50O8
|
574.350570
|
LMPR0106040011
|
Monodesacetyl cephalosporin P1
|
16beta-acetoxy-3alpha,7beta,6alpha-trihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C31H48O7
|
532.340005
|
LMPR0106040012
|
11-ketofusidic acid
|
(-)-16beta-acetoxy-11-oxo-3alphahydroxy-fusida-17(20)Z,24-diene-21-oic acid
|
|
C31H46O6
|
514.329440
|
LMPR0106040013
|
3-epifusidic acid
|
(-)-16beta-acetoxy-3beta,11alpha-dihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C31H48O6
|
516.345090
|
LMPR0106040014
|
11-epifusidic acid
|
(-)-16beta-acetoxy-3alpha,11beta-dihydroxyfusida-17(20)Z,24-diene-21-oic acid
|
|
C31H48O6
|
516.345090
|
LMPR0106040015
|
9,11-Anhydro Fusidic Acid
|
(-)-16beta-acetoxy-3alpha-hydroxyfusida-9(11),17(20)Z,24-triene-21-oic acid
|
|
C31H46O5
|
498.334525
|
LMPR0106040016
|
12-hydroxy-9,11-Anhydro Fusidic Acid
|
(-)-16beta-acetoxy-3alpha,12-dihydroxyfusida-9(11),17(20)Z,24-triene-21-oic acid
|
|
C31H46O6
|
514.329440
|
LMPR0106040017
|
7,8-dehydropseudofusidic acid
|
(-)-16beta-acetoxy-3alpha,12alpha-dihydroxyfusida-7,17(20),24-triene-21-oic acid
|
|
C30H44O6
|
500.313790
|
LMPR0106090003
|
Meliasanine A
|
(5R,9R,10R,13S,14S,16S,17S,20S)-3,6-dione-16-hydroxy-tirucalla-7,24-diene
|
|
C30H46O3
|
454.344695
|
LMPR0106090004
|
Meliasanine B
|
(3R,5R,9R,10R,13S,14S,16S,17S,20S) methyl 6-oxo-3,16-dihydroxy-tirucalla-7,24-dien-20-oate
|
|
C31H48O5
|
500.350175
|
LMPR0106090005
|
Meliasanine C
|
(3S,5R,9R,10R,13S,14S,16S,17S,20S) methyl 6-oxo-3,16-dihydroxy-tirucalla-7,24-dien-20-oate
|
|
C31H48O5
|
500.350175
|
LMPR0105050001
|
Ophiobolin A
|
|
|
C25H36O4
|
400.261360
|
LMPR0106040018
|
Alisol A
|
11beta,23S,24R,25-tetrahydroxy-dammar-13(17)-en-3-one
|
|
C30H50O5
|
490.365825
|
LMPR0102120050
|
(+)-alpha-thujone
|
(1R,4S,5S)-4-methyl-1-(propan-2-yl)bicyclo[3.1.0]hexan-3-one (1R,4S,5S)-thujan-3-one
|
|
C10H16O
|
152.120115
|
LMPR0102110002
|
Hinokitiol
|
2-hydroxy-6-propan-2-ylcyclohepta-2,4,6-trien-1-one
|
|
C10H12O2
|
164.083730
|
LMPR0104080013
|
Momilactone B
|
3alpha-hydroxy-6beta,18;3beta,19-diepoxy-9beta-pimara-7,15-diene-18-one
|
|
C20H26O4
|
330.183110
|
LMPR0104230014
|
Gemmacolide F
|
|
|
C28H34O15
|
610.189775
|
LMPR0104230013
|
Gemmacolide E
|
|
|
C26H33O12Cl
|
572.166058
|
LMPR0104230012
|
Gemmacolide D
|
|
|
C28H35O13Cl
|
614.176623
|
LMPR0104230011
|
Gemmacolide C
|
|
|
C28H37O12Cl
|
600.197358
|
LMPR0104230010
|
Gemmacolide B
|
|
|
C33H45O14Cl
|
700.249788
|
LMPR0104230009
|
Gemmacolide A
|
|
|
C30H39O14Cl
|
658.202838
|
LMPR01071055
|
Roretziaxanthin
|
3-hydroxy-1',16'-didehydro-1',2'-dihydro-2',6'-cyclo-beta-psi-carotene-4,4'-dione
|
|
C40H50O3
|
578.375995
|
LMPR01080071
|
Arthroxanthin
|
2,2'-Bis-(2-ethylidene-propane-1,3-diol)-beta,beta-carotene
|
|
C50H72O4
|
736.543060
|
LMPR0106150065
|
Escin 1a
|
21-tigoyl-22-acetyl-protoaescigenin 3-O[beta-D-glucopyranosyl (1-2)][beta-D-glucopyranosyl (1-4)]-beta-D-glucopyranosiduronic acid
|
|
C55H86O24
|
1130.550910
|
LMPR0106150066
|
Escin 1b
|
21-angeloyl-22-acetyl-protoaescigenin 3-O[beta-D-glucopyranosyl (1-2)][beta-D-glucopyranosyl (1-4)]-beta-D-glucopyranosiduronic acid
|
|
C55H86O24
|
1130.550910
|
LMPR0106150067
|
Escin IIa
|
21-tigloyl-22-acetyl-protoaescigenin 3-O[beta-D-xylopyranosyl (1-2)][beta-D-glucopyranosyl (1-4)]-beta-D-glucopyranosiduronic acid
|
|
C54H84O23
|
1100.540345
|
LMPR0106150068
|
Escin IIb
|
21-angeloyl-22-acetyl-protoaescigenin 3-O[beta-D-xylopyranosyl (1-2)][beta-D-glucopyranosyl (1-4)]-beta-D-glucopyranosiduronic acid
|
|
C54H84O23
|
1100.540345
|
LMPR0106150069
|
Escin IIIa
|
21-angeloyl-22-acetyl-barringtogenol 3-O[beta-D-glucopyranosyl (1-2)][beta-D-glucopyranosyl (1-4)]-beta-D-glucopyranosiduronic acid
|
|
C55H86O23
|
1114.555995
|
LMPR0106150070
|
Barringtogenol C
|
Olean-12-ene-3beta,16alpha,21beta,22alpha,28-pentol
|
|
C30H50O5
|
490.365825
|
LMPR0104030015
|
Haterumaimide Q
|
|
|
C20H31NO4
|
349.225309
|
LMPR0104030016
|
Haterumaimide P
|
|
|
C20H30NO3Cl
|
367.191422
|
LMPR0104030017
|
Haterumaimide O
|
|
|
C22H30NO4Cl
|
407.186337
|
LMPR0104030018
|
Haterumaimide N
|
|
|
C22H32NO5Cl
|
425.196902
|
LMPR0104030019
|
Haterumaimide A
|
|
|
C22H31NO5Cl2
|
459.157930
|
LMPR0104030020
|
Haterumaimide B
|
|
|
C20H27NO4Cl2
|
415.131715
|
LMPR0104030021
|
Haterumaimide C
|
|
|
C20H27NO4Cl2
|
415.131715
|
LMPR0104030022
|
Haterumaimide D
|
|
|
C20H27NO4Cl2
|
415.131715
|
LMPR0104030023
|
Haterumaimide E
|
|
|
C20H29NO4Cl2
|
417.147365
|
LMPR0104030024
|
Haterumaimide F
|
|
|
C20H30NO4Cl
|
383.186337
|
LMPR0104030025
|
Haterumaimide G
|
|
|
C20H28NO4Cl
|
381.170687
|
LMPR0104030026
|
Haterumaimide H
|
|
|
C20H28NO4Cl
|
381.170687
|
LMPR0104030028
|
Chlorolissoclimide
|
|
|
C20H30NO4Cl
|
383.186337
|
LMPR0104030029
|
Dichlorolissoclimide
|
|
|
C20H29NO4Cl2
|
417.147365
|
LMPR0104030030
|
Haterumaimide K
|
|
|
C22H32NO5Cl
|
425.196902
|
LMPR0104030031
|
Haterumaimide J
|
|
|
C20H30NO4Cl
|
383.186337
|